Aims and Scope
Biomarker Insights is a peer-reviewed, open-access research journal where those engaged in biomarker research can turn for rapid communication of the latest advances in the application of biomarkers toward the discovery of new knowledge, and toward the clinical translation of that knowledge to increase the efficacy of practicing clinicians. Papers submitted for review in Biomarker Insights should focus on the following areas:
Biomarkers as tools in decision making
Regulatory acceptance of biomarkers
Biomarker development and validation
Role of collaborations and consortia in biomarker advancement
The "Economics" Behind Personalized Medicine and Pharmacogenomics
Toxicity biomarkers, toxicogenomics
Biomarkers for early efficacy assessment
Genetic biomarkers; genomic biomarkers
Biomarkers in clinical pharmacology
Biomarkers for clinical safety assessment
Biomarkers to monitor and predict disease progression and response to therapy
Clinical validation of biomarkers
Biomarkers as surrogate end-points
Biomarkers as indications for drug therapy
Biomarker assay development and validation
Monitoring response to therapy
Clinical Proteomics: potential of proteomic technologies in diagnostics
Expression signatures as diagnostic/prognostic tools
Imaging biomarkers pharmacodiagnostics, companion diagnostics
Integration of biomarkers into clinical practice guidelines and clinical decision support systems
Integration of biomarkers into mathematical models and algorithms
Standard Author Services
The journal distinguishes itself from others in the field by combining individualized author service with editorial integrity and procedural efficiency. At every stage authors will be introduced to the staff member responsible for their paper and will receive procedural explanations and regular status updates. The progress of authors’ papers is continually monitored by staff, and a staff member is always available to answer authors' questions. This is reflected in our consistently positive author testimonials.
Submission to first editorial decision including rigorous, expert peer review in average four weeks
Rapid publication in two to four weeks after acceptance
No deadlines for corrections to typeset proofs
Paper announcement after publication through scholarly databases, social media, and opted-in newsletters
Open access visibility and flexibility with no restrictions on author archiving
CC-BY-NC licensing to prohibit unrestricted commercial re-use, CC-BY available on request
Article level usage metrics (in beta)
Permanent availability by leading institutional libraries under CLOCKSS and LOCKSS systems
Proactive, professional journal staff
Optional Author Services
Discounted article reprints
English proof reading
Pre-submission paper-matching and editor in chief consultation
Pre-peer review language polishing and paper formatting
Ebook on enhancing article visibility
Social media promotion
Current Article Processing Fees
As an open access journal authors are charged an article processing fee after acceptance for publication by the editor in chief or associate editor. Fees do not vary based on factors like word count or use of color images, and there is no fee charged upon submission. Current fees are given below:
Authors in North America: US$1848
Authors in Japan: ¥220,500
Authors in other countries: €1549
More information on article processing fees and availability of waivers and discounts are available on the article processing fees webpage.
Manuscript Types and Preparation Guidelines
Information on manuscript types accepted for peer review and guidelines for manuscript preparation are available here. A template manuscript, sample manuscript, and pre-submission check list is available here.
All articles are subject to blind independent peer review by reviewers drawn from the journal's editorial board, volunteer peer reviewer pool, and where necessary from Pubmed. Pubmed is used where specialized expertise is unavailable from the other sources. Two to four peer reviewers will be used. Editorial decisions are made by independent editors in chief or associate editors. The editorial process from peer review to first editorial decision takes three to four weeks following acceptance of each paper for peer review.
In the open access business model many editorial decisions result in a fee payment to the publisher. Because of this we maintain a strict distinction between editorial decisions, made by editors in chief or associate editors, and business decisions. Libertas does not make nor attempt to influence editorial decisions. Editorial decision makers receive no incentives to make decisions leading to fee payments.
The journal is committed to high standards of integrity. Authors are required to confirm their compliance with ethical and legal requirements upon submission. Prior to publication all authors must provide signed confirmation of compliance. Where concerns arise the journal will apply the Committee on Publication Ethics guidelines on ethical matters.
Frequency of Publication
Articles are published upon completion of production.
Article citations follow this format:
Authors: Title. Journal [year]:[volume] [first page]-[last page]
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
Correspondence should be sent to . Contact details for Libertas staff are available here.
Additional Information for Authors
I have had a great experience with submitting my cancer prognosis study to Biomarker Insights. The comments from reviewers and associate editor are high quality and insightful. Congratulations and keep up the good work.